UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Tyrosine kinase inhibitors: From rational design to clinical trials

Medicinal research reviews, 2001-11, Vol.21 (6), p.499-512

2001

Volltextzugriff (PDF)

Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis

BBA - Proteins and Proteomics, 2004-03, Vol.1697 (1-2), p.17-27

2004

Volltextzugriff (PDF)

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2310-2323

2000

Volltextzugriff (PDF)

Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors

Journal of medicinal chemistry, 2002-12, Vol.45 (26), p.5687-5693

2002

Volltextzugriff (PDF)

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3601-3616

1997

Volltextzugriff (PDF)

Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching

Bioorganic & medicinal chemistry letters, 2003-09, Vol.13 (18), p.2967-2971

2003

Volltextzugriff (PDF)

The Total Synthesis and Biological Assessment of trans-Epothilone A

Helvetica chimica acta, 2002-11, Vol.85 (11), p.4086-4110

2002

Volltextzugriff (PDF)

Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing

Journal of medicinal chemistry, 2020-12, Vol.63 (23), p.14576-14593

2020

Volltextzugriff (PDF)

The T‐cell fingerprint of MALT1 paracaspase revealed by selective inhibition

Immunology and cell biology, 2018-01, Vol.96 (1), p.81-99

2018

Volltextzugriff (PDF)

Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

The American journal of pathology, 2008-07, Vol.173 (1), p.265-277

2008

Volltextzugriff (PDF)

A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis

Journal of medicinal chemistry, 2016-01, Vol.59 (1), p.132-146

2016

Volltextzugriff (PDF)

Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction

Bioorganic & medicinal chemistry letters, 2014-05, Vol.24 (9), p.2110-2114

2014

Volltextzugriff (PDF)

A General Strategy for Targeting Drugs to Bone

Angewandte Chemie (International ed.), 2015-11, Vol.54 (48), p.14575-14579

International ed. in English, 2015

Volltextzugriff (PDF)

Corrigendum to “Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction” [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]

Bioorganic & medicinal chemistry letters, 2015-03, Vol.25 (6), p.1356-1356

2015

Volltextzugriff (PDF)

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2178-2189

2000

Volltextzugriff (PDF)

Aromatic Interactions with Phenylalanine 691 and Cysteine 828: A Concept for FMS-like Tyrosine Kinase-3 Inhibition. Application to the Discovery of a New Class of Potential Antileukemia Agents

Journal of medicinal chemistry, 2006-07, Vol.49 (15), p.4451-4454

2006

Volltextzugriff (PDF)

Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding

ChemMedChem, 2015-11, Vol.10 (11), p.1884-1891

2015

Volltextzugriff (PDF)

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)

International journal of oncology, 2014-12, Vol.45 (6), p.2267-2277

2014

Volltextzugriff (PDF)

Gezielte Anreicherung von Wirkstoffen am Knochen am Beispiel von allosterischen FPPS-Inhibitoren

Angewandte Chemie, 2015-11, Vol.127 (48), p.14783-14787

2015

Volltextzugriff (PDF)

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

European journal of medicinal chemistry, 2004, Vol.39 (1), p.11-26

2004

Volltextzugriff (PDF)

Purification and characterization of dihydrodipicolinate synthase from pea

Plant physiology (Bethesda), 1992-03, Vol.98 (3), p.813-821

1992

Volltextzugriff (PDF)

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

Blood, 2008-12, Vol.112 (13), p.5161-5170

2008

Volltextzugriff (PDF)

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison

Genes & cancer, 2010-10, Vol.1 (10), p.1021-1032

2010

Volltextzugriff (PDF)

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development

Journal of medicinal chemistry, 1998-08, Vol.41 (18), p.3387-3401

1998

Volltextzugriff (PDF)

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d]pyrimidines as Inhibitors of Receptor Tyrosine Kinases (RTK)

Helvetica chimica acta, 2004-04, Vol.87 (4), p.956-975

2004

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(56)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(25)
Humans
(18)
Biological And Medical Sciences
(17)
Chemistry, Medicinal
(17)
Pharmacology & Pharmacy
(17)
Medical Sciences
(15)
Animals
(13)
Chemistry
(12)
Pharmacology. Drug Treatments
(12)
Physical Sciences
(11)
Structure-Activity Relationship
(11)
Enzyme Inhibitors - Pharmacology
(10)
Mice
(10)
Antineoplastic Agents
(7)
Antineoplastic Agents - Pharmacology
(7)
Female
(7)
Administration, Oral
(6)
Angiogenesis Inhibitors - Pharmacology
(6)
Chemistry, Organic
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tyrosine kinase inhibitors: From rational design to clinical trials

Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching

The Total Synthesis and Biological Assessment of trans-Epothilone A

Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing

The T‐cell fingerprint of MALT1 paracaspase revealed by selective inhibition

Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis

Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction

A General Strategy for Targeting Drugs to Bone

Corrigendum to “Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction” [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

Aromatic Interactions with Phenylalanine 691 and Cysteine 828: A Concept for FMS-like Tyrosine Kinase-3 Inhibition. Application to the Discovery of a New Class of Potential Antileukemia Agents

Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)

Gezielte Anreicherung von Wirkstoffen am Knochen am Beispiel von allosterischen FPPS-Inhibitoren

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

Purification and characterization of dihydrodipicolinate synthase from pea

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d]pyrimidines as Inhibitors of Receptor Tyrosine Kinases (RTK)

Suchergebnisse filtern